As of 2025-09-18, the Relative Valuation of Constellation Pharmaceuticals Inc (CNST) is (55.76) USD. This relative valuation is based on P/E multiples. With the latest stock price at 33.99 USD, the upside of Constellation Pharmaceuticals Inc based on Relative Valuation is -264.0%.
The range of the Relative Valuation is (47.49) - (60.32) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.4x - 20.5x | 18.0x |
| Forward P/E multiples | 16.1x - 23.8x | 20.0x |
| Fair Price | (47.49) - (60.32) | (55.76) |
| Upside | -239.7% - -277.5% | -264.0% |
| Date | P/E |